Lilly Acquires Neuroscience Diagnostics Developer Avid Radiopharmaceuticals
By Editorial Team
Pharma Deals Review: Vol 2010 Issue 9 (Table of Contents)
Published: 30 Nov-2010
DOI: 10.3833/pdr.v2010.i9.1401 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Lilly struck a different note by acquiring a diagnostics, rather than therapeutics developer, but stuck to its innovation based strategy in acquisitions...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS